Difference between revisions of "Kuba K, et al, Nat Med (2005), cited as Ref 21 in DOI:10.1007/s11886-020-01292-3 (Q10530)"
Jump to navigation
Jump to search
(Created claim: Issue (P104): 8, #quickstatements; #temporary_batch_1592505440125) |
(Created claim: Volume (P103): 11, #quickstatements; #temporary_batch_1592505530458) |
||
| Property / Volume | |||
| + | 11 | ||
| Property / Volume: 11 / rank | |||
| + | Normal rank | ||
Revision as of 18:39, 18 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Kuba K, et al, Nat Med (2005), cited as Ref 21 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury (English)
0 references
Kuba K
0 references
Imai Y
0 references
Rao S
0 references
Gao H
0 references
Guo F
0 references
Guan B
0 references
Huan Y
0 references
Yang P
0 references
Zhang Y
0 references
Deng W
0 references
Bao L
0 references
Zhang B
0 references
Liu G
0 references
Wang Z
0 references
Chappell M
0 references
Liu Y
0 references
Zheng D
0 references
Leibbrandt A
0 references
Wada T
0 references
Slutsky AS
0 references
2005
0 references
Nat Med
0 references
875-879
0 references
8
0 references
11
0 references
